Telecommunication Methods for Cancer Medication Adherence

Overseen By Elizabeth Prechtel Dunphy, DNP

Age: 18+

Sex: Any

Trial Phase: Academic

Sponsor: Abramson Cancer Center at Penn Medicine

Must be taking: Oral cancer agents

Disqualifiers: Chemoradiation, others

No Placebo Group All trial participants will receive the active study treatment (no placebo)

Compensation: Varies

Number of Visits: 8

76 Participants Needed

Trial Summary

What is the purpose of this trial?

The objective of this study is to evaluate adherence to oral oncologic medication regimens utilizing a standardized education tool to explain the dosing, side effects and purpose of oral chemotherapy via televideo or telephonic interactions. Researchers aim to evaluate whether the modality of education and monitoring impact adherence.

Eligibility Criteria

This trial is for cancer patients who need to take oral chemotherapy and are willing to be monitored over the phone or through video calls. The study will include those who can follow a standardized education protocol about their medication.

Inclusion Criteria

I am starting treatment with a pill for cancer.

Lives in Pennsylvania

Receives cancer care at Abramson Cancer Center at Penn Presbyterian Medical Center

Exclusion Criteria

Does not have access to the UPENN televideo platform

Does not live in Pennsylvania

I am unable to give my own consent for medical procedures.

Timeline

Screening

Participants are screened for eligibility to participate in the trial

1-2 weeks

Education and Initial Assessment

Initial medication education using a standardized tool and assessment of adherence and toxicity

1 week

1 visit (virtual)

Monitoring and Assessment

Regular monitoring of adherence and toxicity through televideo or telephonic interactions

16 weeks

7 visits (virtual)

Follow-up

Participants are monitored for safety and effectiveness after treatment

4 weeks

Treatment Details

Interventions

• Intervention A- Telephone
• Intervention B- Televideo

Trial Overview The study is testing if teaching patients about their oral chemotherapy using phone calls (Intervention A) or video calls (Intervention B) affects how well they stick to their medication regimen.

Participant Groups

Group I: Telephonic and telemedicine evaluation Experimental Treatment 2 Interventions

Patients will be randomized to telephonic or telemedicine evaluation during participation in the study

Who Is Running the Clinical Trial?

Abramson Cancer Center at Penn Medicine

Lead Sponsor

Trials

425

Recruited

464,000+